Iambic Therapeutics, Inc. funding
Iambic Therapeutics, Inc., a biotechnology company based in San Diego, CA, filed a Form D with the SEC on September 9, 2026 and reported $66M raised of a $66.5M offering. It filed 3 new offerings in this period, totaling $193M.
Amount raised$66M
Offering size$66.5M
Filed with the SECSeptember 9, 2026
First saleAugust 14, 2026
IndustryBiotechnology
SecuritiesDebt
LocationSan Diego, CA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far16
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Sep 9
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| September 9, 2026 | $66M | $66.5M | Debt |
| April 8, 2026 | $27.8M | $50M | Equity |
| November 21, 2025 | $99.3M | $125M | Equity |
Other health care rounds in California
Alpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyCaspian Therapeutics, Inc.$50M · Sep 23BiotechnologyEstuary Biotherapeutics, Inc.$40.7M · Oct 16BiotechnologyPFARADIGM Health, Inc.$31.1M · Sep 28Other Health CareTrellis Bioscience, Inc.$22.9M · Oct 21BiotechnologyAltay Therapeutics, Inc.$15.7M · Oct 2BiotechnologyAdela, Inc.$12M · Oct 19Biotechnology